These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9532594

  • 1. The release mechanism of an oral controlled-release delivery system for indomethacin.
    Talukdar MM, Rombaut P, Kinget R.
    Pharm Dev Technol; 1998 Feb; 3(1):1-6. PubMed ID: 9532594
    [Abstract] [Full Text] [Related]

  • 2. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength.
    Mikac U, Sepe A, Kristl J, Baumgartner S.
    J Control Release; 2010 Aug 03; 145(3):247-56. PubMed ID: 20417675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.
    Peerapattana J, Otsuka K, Otsuka M.
    Biomed Mater Eng; 2004 Aug 03; 14(3):293-301. PubMed ID: 15299241
    [Abstract] [Full Text] [Related]

  • 5. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
    Vendruscolo CW, Andreazza IF, Ganter JL, Ferrero C, Bresolin TM.
    Int J Pharm; 2005 May 30; 296(1-2):1-11. PubMed ID: 15885450
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
    Fukuda M, Peppas NA, McGinity JW.
    Int J Pharm; 2006 Mar 09; 310(1-2):90-100. PubMed ID: 16413153
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of hydrophobic materials as matrices for controlled-release drug delivery.
    Quadir MA, Rahman MS, Karim MZ, Akter S, Awkat MT, Reza MS.
    Pak J Pharm Sci; 2003 Jul 09; 16(2):17-28. PubMed ID: 16414573
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of guar gum in the preparation of sustained-release matrix tablets.
    Khullar P, Khar RK, Agarwal SP.
    Drug Dev Ind Pharm; 1998 Nov 09; 24(11):1095-9. PubMed ID: 9876566
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS, Khan F, Hossain M, Khan MZ, Azad MA, Reza MS.
    Pak J Pharm Sci; 2009 Jul 09; 22(3):303-7. PubMed ID: 19553179
    [Abstract] [Full Text] [Related]

  • 15. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S.
    Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477
    [Abstract] [Full Text] [Related]

  • 16. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.
    Int J Pharm; 2005 Nov 04; 304(1-2):91-101. PubMed ID: 16154302
    [Abstract] [Full Text] [Related]

  • 17. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
    Asghar LF, Azeemuddin M, Jain V, Chandran S.
    Drug Deliv; 2009 May 04; 16(4):205-13. PubMed ID: 19514981
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.